A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma

Shiao Pei Weathers, Xiaosi Han, Diane D. Liu, Charles A. Conrad, Mark R. Gilbert, Monica E. Loghin, Barbara J. O’Brien, Marta Penas-Prado, Vinay K. Puduvalli, Ivo Tremont-Lukats, Rivka R. Colen, W. K.Alfred Yung, John F. de Groot

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences